<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03954418</url>
  </required_header>
  <id_info>
    <org_study_id>MM_PO_MP_2019</org_study_id>
    <nct_id>NCT03954418</nct_id>
  </id_info>
  <brief_title>Transport of Artificial Sweeteners During Pregnancy</brief_title>
  <official_title>Trans-placental Transport and Foetal Accumulation of Artificial Sweeteners</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      With obesity on the rise worldwide more and more young women are also affected, leading to a&#xD;
      higher prevalence of obese pregnant women and pregnant women with diabetes.&#xD;
&#xD;
      Children of these women are in risk of developing obesity during childhood which again leads&#xD;
      to overweight during adult life resulting in life-style related diseases such as diabetes and&#xD;
      cardio-vascular disease.&#xD;
&#xD;
      Overweight and diabetic women are currently advised to substitute sugar sweetened beverages&#xD;
      with artificially sweetened beverages to lower caloric intake and avoid fluctuations in blood&#xD;
      glucose to avoid complications during pregnancy for both mother and child.&#xD;
&#xD;
      Recent studies suggest that high intake of artificial sweeteners during pregnancy increases&#xD;
      the risk of the child developing obesity. If this is indeed true, the current guidelines have&#xD;
      the opposite of the wanted and children already in risk of overweight are exposed to extra&#xD;
      risk.&#xD;
&#xD;
      To investigate if artificial sweeteners can affect the foetus, the investigators wish to&#xD;
      examine whether artificial sweeteners can cross the placenta.&#xD;
&#xD;
      The study is a clinical trial in which 40 women will be enrolled. 30 participants will drink&#xD;
      a diet soft drink 2 hours before a caesarean section and 10 controls will refrain from&#xD;
      intake. After birth the investigators will obtain a blood sample from the mother and from the&#xD;
      umbilical cord and a placental biopsy and measure the contents of artificial sweeteners.&#xD;
      Furthermore, the investigators will obtain a sample of amniotic fluid to examine if the&#xD;
      sweeteners are excreted into the amniotic fluid.&#xD;
&#xD;
      The results ultimately have the potential to change the current guidelines on diet for&#xD;
      overweight and diabetic women during pregnancy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Actual">September 1, 2020</completion_date>
  <primary_completion_date type="Actual">February 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>We wish to conduct an interventional, open-label study in which 40 women undergoing planned caesarean section will be included. In the intervention-group divided between:&#xD;
10 women with IUGR-child, 10 women with diabetes, 10 healthy women. We will use a control group of 10 healthy women who will refrain from intake.&#xD;
The participants will drink an artificially sweetened soft drink 2 to 4 hours before planned c-section.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mothers blood</measure>
    <time_frame>Time of birth</time_frame>
    <description>Concentration of artificial sweeteners in blood from the mother</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Placenta</measure>
    <time_frame>Time of birth</time_frame>
    <description>Concentration of artificial sweeteners in placenta</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Umbilical cord</measure>
    <time_frame>Time of birth</time_frame>
    <description>Concentration of artificial sweeteners in blood from umbilical cord</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Amniotic fluid</measure>
    <time_frame>Time of birth</time_frame>
    <description>Concentration of artificial sweeteners in amniotic fluid</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>Pregnancy Related</condition>
  <condition>Diabetes</condition>
  <condition>IUGR</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will drink an artificially sweetened drink 2-4 hours before elective caesarean section.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in the control group will refrain from intake of artificial sweeteners.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Acesulfame K, cyclamate, saccharine, aspartame</intervention_name>
    <description>Intervention group receives a combination of multiple artificial sweeteners</description>
    <arm_group_label>Intervention group</arm_group_label>
    <other_name>Artificial sweeteners</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective caesarean section&#xD;
&#xD;
          -  Child with IUGR (10 subjects)&#xD;
&#xD;
          -  Diabetes (10 subjects)&#xD;
&#xD;
          -  Other reasons for caesarean section(10 healthy subjects in intervention + 10 healthy&#xD;
             controls)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute caesarean section&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Ovesen, DMSc</last_name>
    <role>Study Director</role>
    <affiliation>per.ovesen@clin.au.dk</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Obstetrics and Gynecology</name>
      <address>
        <city>Aarhus</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 15, 2019</study_first_submitted>
  <study_first_submitted_qc>May 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2019</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Artificial sweeteners</keyword>
  <keyword>Non-nutritive sweeteners</keyword>
  <keyword>Caesarean section</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

